(Q46418424)

22 December 2017

title

Incidence and causes for failure of treatment of women with proven osteoporosis (English)

1 reference

22 December 2017

0 references

Noah Zafran

1

1 reference

22 December 2017

Zvi Liss

2

1 reference

22 December 2017

Ronit Peled

3

1 reference

22 December 2017

Michael Sherf

4

1 reference

22 December 2017

Haim Reuveni

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

2 April 2005

1 reference

22 December 2017

Osteoporosis International

published in

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

issue

11

1 reference

22 December 2017

page(s)

1375-1383

1 reference

22 December 2017

Compliance with pharmacologic therapy for osteoporosis

cites work

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study

1 reference

12 December 2020

Medication compliance in the elderly.

1 reference

12 December 2020

Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence

1 reference

12 December 2020

The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization

1 reference

12 December 2020

Prevalence of osteoporosis and related risk factors in UK women in the seventh decade: osteoporosis case finding by clinical referral criteria or predictive model?

1 reference

12 December 2020

Awareness of osteoporosis and compliance with management guidelines in patients with newly diagnosed low-impact fractures

1 reference

12 December 2020

Osteoporosis and proximal femoral fractures in the female elderly of Jerusalem

1 reference

12 December 2020

Determinants of long-term hormone replacement therapy and reasons for early discontinuation

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

The measurement of clinical pain intensity: a comparison of six methods

1 reference

12 December 2020

Advances in osteoporosis therapy. 2003 update of practical guidelines

1 reference

12 December 2020

An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture

1 reference

12 December 2020

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

12 December 2020

Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial

1 reference

12 December 2020

Treatment of osteoporosis among older adults discharged from hospital in Italy

1 reference

12 December 2020

American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis

1 reference

12 December 2020

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Drug defaulting. I. Determinants of compliance

1 reference

12 December 2020

Consensus Development Conference on Osteoporosis. Hong Kong, April 1-2, 1993

1 reference

12 December 2020

The socioeconomic burden of fractures: today and in the 21st century

1 reference

12 December 2020

Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing

1 reference

12 December 2020

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

12 December 2020

Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes

1 reference

12 December 2020

Women's attitudes towards menopause and hormone replacement therapy

1 reference

12 December 2020

Osteoporosis: part II. Nonpharmacologic and pharmacologic treatment.

1 reference

12 December 2020

Compliance with hormonal replacement therapy.

1 reference

12 December 2020

Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis

1 reference

12 December 2020

Treatment of osteoporosis: are physicians missing an opportunity?

1 reference

12 December 2020

Clinical guidelines for the treatment of osteoporosis in Japan

1 reference

12 December 2020

Nonadherence and osteoporosis treatment preferences of older women: a qualitative study.

1 reference

12 December 2020

Compliance of osteoporotic patients with different treatment regimens

1 reference

12 December 2020

Interventions for helping patients to follow prescriptions for medications

1 reference

12 December 2020

Tolerability and compliance with risedronate in clinical practice

1 reference

12 December 2020

Outpatient costs of osteoporosis in a national health insurance population

1 reference

12 December 2020

Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older

1 reference

12 December 2020

The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members

1 reference

12 December 2020

10.1007/S00198-005-1838-Z

Identifiers

DOI

1 reference

22 December 2017

release_wx56odxmp5ej7itfuj7xsg6avi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wx56odxmp5ej7itfuj7xsg6avi

24 November 2022

mapped directly with Wikidata item

1 reference

22 December 2017